Zavante Therapeutics
Latest round
- Series A
Last raised
- Mar 2016
Total raised
- $45M
Investors
- 3
About Zavante Therapeutics
Founded in 2015 and headquartered in San Diego, US, Zavante Therapeutics specializes in antibiotic development. The company was acquired by Nabriva Therapeutics GmbH in July 2018.Zavante Therapeutics is focused on developing ZOLYD™ (fosfomycin for injection), an investigational antibiotic for treating multi-drug resistant infections in hospitalized patients. It primarily targets complicated urinary tract infections and has potential applications for complicated intra-abdominal infections and hospital-acquired bacterial pneumonia.Zavante Therapeutics generates revenue through partnerships and direct sales of ZOLYD to hospitals and healthcare systems. The company has structured agreements with healthcare providers to ensure access to its antibiotic, facilitating treatment for patients with critical infections.Zavante Therapeutics aims to expand its product line and enhance market presence. The company is focused on potential new products to address additional indications and plans to broaden its reach within North America.00 mn will support these initiatives, enhancing research capabilities and market development efforts.
Who invested in Zavante Therapeutics
3 investors across 1 round
See all investors in Zavante Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 30, 2016
Amount
$45M
Investors
Questions about Zavante Therapeutics
Who invested in Zavante Therapeutics?
Zavante Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zavante Therapeutics raised?
Zavante Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Zavante Therapeutics last raise money?
Zavante Therapeutics's most recent round on record is a Series A, in Mar 2016.
What does Zavante Therapeutics do?
Founded in 2015 and headquartered in San Diego, US, Zavante Therapeutics specializes in antibiotic development.
Where is Zavante Therapeutics headquartered?
Zavante Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Zavante Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Zavante Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Zavante Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.